1. Home
  2. CIX vs FDMT Comparison

CIX vs FDMT Comparison

Compare CIX & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CompX International Inc.

CIX

CompX International Inc.

N/A

Current Price

$22.75

Market Cap

289.5M

ML Signal

N/A

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

HOLD

Current Price

$9.82

Market Cap

504.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIX
FDMT
Founded
1993
2013
Country
United States
United States
Employees
N/A
196
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
289.5M
504.4M
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
CIX
FDMT
Price
$22.75
$9.82
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$33.50
AVG Volume (30 Days)
2.0K
618.9K
Earning Date
03-04-2026
03-18-2026
Dividend Yield
9.52%
N/A
EPS Growth
17.04
18.79
EPS
1.58
N/A
Revenue
$158,285,000.00
$85,209,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.28
P/E Ratio
$14.56
N/A
Revenue Growth
8.46
230194.60
52 Week Low
$17.89
$2.24
52 Week High
$32.30
$12.34

Technical Indicators

Market Signals
Indicator
CIX
FDMT
Relative Strength Index (RSI) 41.95 62.14
Support Level $21.50 $9.85
Resistance Level $23.25 $10.48
Average True Range (ATR) 0.55 0.54
MACD -0.13 0.10
Stochastic Oscillator 5.36 81.46

Price Performance

Historical Comparison
CIX
FDMT

About CIX CompX International Inc.

Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's reportable operating segment includes Security Products and Marine Components. It generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Geographically, the company generates maximum revenue from the United States, followed by Canada, Mexico, and other markets.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Share on Social Networks: